02-031 C.M.R. ch. 490, § 2 - Purpose

Current through 2022-14, April 6, 2022

The purpose of this rule is to clarify the standards applicable to written informed consent forms required to be completed by persons required to take a test for the presence of the antibody to the Human Immunodeficiency Virus (HIV) or for the Human Immunodeficiency Antigen by an insurer, nonprofit hospital service organization, nonprofit medical service organization, or a nonprofit health care plan, to establish standards for post-test counseling required to be provided to persons subject to testing as required by 5 M.R.S.A. §19203-A, and to establish standards for medical and lifestyle application questions and underwriting.

Notes

02-031 C.M.R. ch. 490, § 2

The following state regulations pages link to this page.



State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.